ABBOTT LABORATORIES — Director's Dealing 2013

Page 1 of 1

SEC FORM 4

SEC Form 4

FORM 4

==> picture [484 x 425] intentionally omitted <==

----- Start of picture text ----- FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION OMB APPROVALWashington, D.C. 20549OMB Number: 3235-0287Check this box if no longer subject to STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Expires: December 31, 2014Section 16. Form 4 or Form 5 Estimated average burdenobligations may continue. Instruction 1(b). See Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934or Section 30(h) of the Investment Company Act of 1940 hours per response: 0.51. Name and Address of Reporting Person [*] 2. Issuer Name and Ticker or Trading Symbol 5. Relationship of Reporting Person(s) to IssuerABBOTT LABORATORIES [ ABT ] (Check all applicable)Blaser Brian J Director 10% OwnerX Officer (give title Other (specifybelow) below)(Last) (First) (Middle) 3. Date of Earliest Transaction (Month/Day/Year)06/01/2012 Executive Vice President100 ABBOTT PARK ROAD(Street) 4. If Amendment, Date of Original Filed (Month/Day/Year) 6. Individual or Joint/Group Filing (Check ApplicableLine)ABBOTTIL 60064 X Form filed by One Reporting PersonPARKForm filed by More than One ReportingPerson(City) (State) (Zip)Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned1. Title of Security (Instr. 3) 2. Transaction 2A. Deemed 3. 4. Securities Acquired (A) 5. Amount of 6. 7. NatureDate Execution Date, Transaction or Disposed Of (D) (Instr. Securities Ownership of Indirect(Month/Day/Year) if any Code (Instr. 3, 4 and 5) Beneficially Form: Direct Beneficial(Month/Day/Year) 8) Owned (D) or OwnershipFollowing Indirect (I) (Instr. 4)(A) Reported (Instr. 4)Code V Amount or Price Transaction(s)(D) (Instr. 3 and 4)Common shares without par value 06/01/2012 A 5,500 [(1)] A $0 83,724 DTable II - Derivative Securities Acquired, Disposed of, or Beneficially Owned(e.g., puts, calls, warrants, options, convertible securities)1. Title of 2. 3. Transaction 3A. Deemed 4. 5. Number 6. Date Exercisable and 7. Title and Amount 8. Price of 9. Number 10. 11. NatureDerivative Conversion Date Execution Date, Transaction of Expiration Date of Securities Derivative of Ownership of IndirectSecurity or Exercise (Month/Day/Year) if any Code (Instr. Derivative (Month/Day/Year) Underlying Security derivative Form: Beneficial(Instr. 3) Price of (Month/Day/Year) 8) Securities Derivative Security (Instr. 5) Securities Direct (D) OwnershipDerivative Acquired (Instr. 3 and 4) Beneficially or Indirect (Instr. 4)Security (A) or Owned (I) (Instr. 4)Disposed Followingof (D) Reported(Instr. 3, 4 Transactionand 5) (s) (Instr. 4)AmountorNumberDate Expiration ofCode V (A) (D) Exercisable Date Title SharesOption(right to buy) [(2)] $60.96 06/01/2012 A 10,100 06/01/2013 05/31/2022 Common shares 10,100 $0 10,100 DExplanation of Responses:----- End of picture text -----

1. These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

2. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 3,367 shares on 06/01/2013; 3,366 shares on 06/01/2014; and 3,367 shares on 06/01/2015.

John A. Berry, by power of 06/05/2012 attorney for Brian J. Blaser ** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

• ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

• Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

http://www.sec.gov/Archives/edgar/data/1800/000117911012009645/xslF345X03/ed...

09/05/2013